- Home
- FGL vs ACXP Comparison
FGL vs ACXP Comparison
Compare FGL & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- ACXP
- Stock Information
- Founded
- FGL 2021
- ACXP 2017
- Country
- FGL Malaysia
- ACXP United States
- Employees
- FGL N/A
- ACXP N/A
- Industry
- FGL
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- FGL
- ACXP Health Care
- Exchange
- FGL NYSE
- ACXP Nasdaq
- Market Cap
- FGL 33.2M
- ACXP 31.4M
- IPO Year
- FGL 2024
- ACXP 2021
- Fundamental
- Price
- FGL $1.87
- ACXP $0.88
- Analyst Decision
- FGL
- ACXP Strong Buy
- Analyst Count
- FGL 0
- ACXP 1
- Target Price
- FGL N/A
- ACXP $12.00
- AVG Volume (30 Days)
- FGL 1.1M
- ACXP 455.1K
- Earning Date
- FGL 12-17-2024
- ACXP 03-14-2025
- Dividend Yield
- FGL N/A
- ACXP N/A
- EPS Growth
- FGL 45.69
- ACXP N/A
- EPS
- FGL 0.04
- ACXP N/A
- Revenue
- FGL $23,268,519.00
- ACXP N/A
- Revenue This Year
- FGL N/A
- ACXP N/A
- Revenue Next Year
- FGL N/A
- ACXP N/A
- P/E Ratio
- FGL $49.55
- ACXP N/A
- Revenue Growth
- FGL 336.06
- ACXP N/A
- 52 Week Low
- FGL $1.25
- ACXP $0.68
- 52 Week High
- FGL $5.26
- ACXP $4.15
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- ACXP 49.25
- Support Level
- FGL N/A
- ACXP $0.68
- Resistance Level
- FGL N/A
- ACXP $1.25
- Average True Range (ATR)
- FGL 0.00
- ACXP 0.10
- MACD
- FGL 0.00
- ACXP 0.02
- Stochastic Oscillator
- FGL 0.00
- ACXP 35.61
About FGL FOUNDER GROUP LTD
Founder Group Ltd acts as an end-to-end Engineering, Procurement, Construction, and Commissioning solutions provider for solar PV facilities in Malaysia. The segments of the company are large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects of the company are utility-scale solar PV power plants with installed generating capacity of 1 MWac or more, and C&I projects of the company are smaller-scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their consumption at factories, warehouses, and commercial stores. The company derives its revenue from Malaysia.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.